P Bager1, J F Dahlerup. 1. Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Abstract
BACKGROUND:Nonvariceal acute upper gastrointestinal bleeding (AUGIB) is often accompanied by post-discharge anaemia. AIM: To investigate whether iron treatment can effectively treat anaemia and to compare a 3-month regimen of oral iron treatment with a single administration of intravenous iron prior to discharge. METHODS:Ninety-seven patients with nonvariceal AUGIB and anaemia were enrolled in a double-blind, placebo-controlled, randomised study. The patients were allocated to one of three groups, receiving a single intravenous administration of 1000 mg of iron; oral iron treatment, 200 mg daily for 3 months; or placebo, respectively. The patients were followed up for 3 months. RESULTS: From week 4 onwards, patients receiving treatment had significantly higher haemoglobin levels compared with patients who received placebo only. At the end of treatment, the proportion of patients with anaemia was significantly higher in the placebo group (P < 0.01) than in the treatment groups. Intravenous iron appeared to be more effective than oral iron in ensuring sufficient iron stores. CONCLUSIONS: Iron treatment is effective and essential for treating anaemia after nonvariceal acute upper gastrointestinal bleeding. The route of iron supplementation is less important in terms of the increase in haemoglobin levels. Iron stores are filled most effectively if intravenous iron supplementation is administered (ClinicalTrials.gov identifier: NCT00978575).
RCT Entities:
BACKGROUND: Nonvariceal acute upper gastrointestinal bleeding (AUGIB) is often accompanied by post-discharge anaemia. AIM: To investigate whether iron treatment can effectively treat anaemia and to compare a 3-month regimen of oral iron treatment with a single administration of intravenous iron prior to discharge. METHODS: Ninety-seven patients with nonvariceal AUGIB and anaemia were enrolled in a double-blind, placebo-controlled, randomised study. The patients were allocated to one of three groups, receiving a single intravenous administration of 1000 mg of iron; oral iron treatment, 200 mg daily for 3 months; or placebo, respectively. The patients were followed up for 3 months. RESULTS: From week 4 onwards, patients receiving treatment had significantly higher haemoglobin levels compared with patients who received placebo only. At the end of treatment, the proportion of patients with anaemia was significantly higher in the placebo group (P < 0.01) than in the treatment groups. Intravenous iron appeared to be more effective than oral iron in ensuring sufficient iron stores. CONCLUSIONS:Iron treatment is effective and essential for treating anaemia after nonvariceal acute upper gastrointestinal bleeding. The route of iron supplementation is less important in terms of the increase in haemoglobin levels. Iron stores are filled most effectively if intravenous iron supplementation is administered (ClinicalTrials.gov identifier: NCT00978575).
Authors: Jürgen Stein; Susan Connor; Garth Virgin; David Eng Hui Ong; Lisandro Pereyra Journal: World J Gastroenterol Date: 2016-09-21 Impact factor: 5.742
Authors: Luis Ferrer-Barceló; Laura Sanchis Artero; Javier Sempere García-Argüelles; Pilar Canelles Gamir; Javier P Gisbert; Luis Manuel Ferrer-Arranz; Ana Monzó Gallego; Lydia Plana Campos; Jose Mª Huguet Malavés; Marisol Luján Sanchis; Lucía Ruiz Sánchez; Susana Barceló Cerdá; Enrique Medina Chuliá Journal: Aliment Pharmacol Ther Date: 2019-06-14 Impact factor: 8.171
Authors: Kyle J Fortinsky; Myriam Martel; Roshan Razik; Gillian Spiegle; Zane R Gallinger; Samir C Grover; Katerina Pavenski; Adam V Weizman; Lukasz Kwapisz; Sangeeta Mehta; Sarah Gray; Alan N Barkun Journal: Can J Gastroenterol Hepatol Date: 2016-06-28